Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
the researcher the opportunity to join a dynamic, well-supported multi-disciplinary team within the research-intensive School of Law and Criminology – the largest criminology team in Ireland - while developing
-
component sources such as roots and microbes – by developing and maintaining both custom and off-the-shelf instruments in field operation. We have developed custom built ‘minirhizotron’ instruments to image
-
developing next-generation antimicrobial peptide (AMP)-based solutions targeting vaginal fungal infections, particularly Recurrent Vulvovaginal Candidiasis (RVVC). The project combines microbiology, molecular
-
a strong understanding of societal challenges related to workforce development and sustainability. They will work alongside a diverse, multidisciplinary team of researchers, industry leaders, and
-
climate regeneration and Nature-based Solutions in deprived areas through the development of innovative co-analysis, co-design, and co-monitoring tools and methodologies for engaging with the community
-
, Netherlands, the newly funded scientific study, “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance” will bring 7 leading
-
prepare responses for these events, e.g. mobilising crews, assessing damage, allocating resources, managing risk etc. are essential requirements shared by most emergency events, as well as how to do
-
Investigator, Dr Lijuan Qian as part of a small team of community-engaged ethnomusicological researchers. The Position will focus on technical development for music and corpus deposit of several ethnic minority
-
collaborators in the Royal College of Surgeons in Ireland, Maynooth University and the University of Pisa, Italy. The aim of this project is to develop effective antimicrobial therapies which can be efficiently
-
Cork (UCC). UCC CTG will develop an efficient and coordinated cancer clinical trials infrastructure regionally which can “provide Irish patients access to a diverse portfolio of high-quality, safe and